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ABSTRACT Crystallization of the mutated hemoglobin, HbC, which occurs inside red blood cells of patients expressing bC-
globin and exhibiting the homozygous CC and the heterozygous SC (in which two mutant b-globins, S and C, are expressed)
diseases, is a convenient model for processes underlying numerous condensation diseases. As a ﬁrst step, we investigated the
molecular-level mechanisms of crystallization of this protein from high-concentration phosphate buffer in its stable carbomonoxy
form using high-resolution atomic force microscopy. We found that in conditions of equilibrium with the solution, the crystals’
surface reconstructs into four-molecule-wide strands along the crystallographic a (or b) axis. However, the crystals do not grow
by the alignment of such preformed strands. We found that the crystals grow by the attachment of single molecules to suitable
sites on the surface. These sites are located along the edges of new layers generated by two-dimensional nucleation or by
screw dislocations. During growth, the steps propagate with random velocities, with the mean being an increasing function of
the crystallization driving force. These results show that the crystallization mechanisms of HbC are similar to those found for
other proteins. Therefore, strategies developed to control protein crystallization in vitro may be applicable to pathology-related
crystallization systems.
INTRODUCTION
Hemoglobin (Hb) C is a mutated Hb, which differs from the
most common variant, HbA, by a single mutation at the sixth
amino acid position of the b subunit that replaces the
negatively charged glutamic acid with a positively charged
lysine (b6 Glu/Lys) (Hunt and Ingram, 1958). In its
oxygenated, R state, HbC forms crystals inside red blood
cells. The intraerythrocytic crystals contribute to the clinical
pathogenesis of the CC disease, a mild and chronic hemolytic
anemia (Lawrence et al., 1991; Lessin et al., 1969). Oxy-HbC
crystals also form in red cells of patients with the SC disease,
who are doubly heterozygous for both HbS and HbC. SC
disease is a severe, life-threatening condition (Nagel and
Lawrence, 1991). Thus, data on the mechanisms and
dynamics of HbC crystallization, including at the molecular
level, contributes to the understanding of the pathogenesis of
the CC and SC diseases, and may be relevant to the other
protein condensation diseases: sickle cell anemia (Eaton and
Hofrichter, 1990), the eye cataract (Benedek et al., 1999),
Alzheimer’s (Kelly, 2000), the prion diseases (Bucciantini
et al., 2002; Koo et al., 1999), and others.
Previous observations of the formation of HbC crystals in
osmotically dehydrated red blood cells were interpreted in
terms of a pathway involving formation of small ribbon-like
‘‘paracrystals,’’ followed by their alignment into tetragonal
and hexagonal crystals (Charache et al., 1967). The suggested
mechanism of alignment of the microribbons is similar to the
one implied for the otherb6 Hb variant, deoxy-HbS (Bluemke
et al., 1988; Lessin et al., 1969;Makinen andSigountos, 1984;
Potel et al., 1984). This pathway is at odds with the
crystallization mechanism established for a broad variety of
proteins under a broad range of conditions (McPherson et al.,
2000; Vekilov and Chernov, 2002)—in all cases crystalliza-
tion occurs by the association of single molecules into an
existing crystal. Thus, in situ monitoring of the elementary
acts of molecular attachment to the crystals are needed to
decide if indeed hemoglobin crystallization follows a pathway
distinct from the one of most other proteins.
In preceding studies, we found that, similar to many other
proteins, the solubility of the protein has a strong retrograde
dependence on temperature (Feeling-Taylor et al., 1999). We
analyzed the thermodynamics of HbC crystallization and
found a high positive enthalpy (Vekilov et al., 2002). This
means that the speciﬁc interactions favor HbC molecules in
the solute state, and HbC crystallization is only possible
because of a huge entropy gain, likely stemming from the
release of up to 10 water molecules per protein intermolecular
contact. Such contacts have been deﬁned as hydrophobic
attraction (Chandler, 2002; Eisenberg and Kauzmann, 1969).
Thus, our data suggest that the greater propensity for R-state
HbC crystallization is attributable to the increased hydropho-
bicity resulting from conformational changes that accompany
the HbC mutation. We also found that the interactions
between the HbC, HbA, and HbS molecules in solution are
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dominated by chemically speciﬁc binding between the
surfaces of Hb molecules that are adjacent in the respective
solid phase, and that the contributions of the electrostatic
interactions are insigniﬁcant at electrolyte concentrations
$0.05 M (Vekilov et al., 2002). These observations do not
reveal any speciﬁcity of HbC crystallization that may underlie
a crystallizationmechanismdifferent from the one established
for many other proteins. In addition, microscopic observa-
tions and determinations of the nucleation statistics showed
that the crystals of HbC nucleate and grow by the attachment
of native molecules from the solution (Vekilov et al., 2002).
This article is focused on the mechanisms of growth of the
HbC crystals. We employ atomic force microscopy (AFM)
in situ, during the growth of the crystals from supersaturated
solutions, or in saturated solutions, i.e., when the crystals are
in a dynamic equilibrium with the solution. Because of the
higher stability of CO-HbC compared with Oxy-HbC, we
used the carbomonoxy form as representative of the R-state
HbC. The structure of carbomonoxy-HbC was recently
determined (Dewan et al., 2002) using crystals grown under
conditions analogous to those employed here.
Crystallization was carried out at concentration of the
potassium phosphate buffer of 1.9 M, at pH 7.35. These high
concentrations of the electrolyte signiﬁcantly lower the
solubility of the hemoglobin and allow high relative super-
saturations at low concentrations of the precious protein.
Attempts to carry out crystallization studies at low buffer
concentrations yielded crystals with phosphate in the range
0.6–1.6 M only if polyethylene glycol is added; at even lower
phosphate concentrations no crystallization of CO-HbC
occurs. The interactions and thermodynamics in protein-
water-polymer systems are completelydifferent fromasystem
that does not contain the polymer and we did not consider
results obtained with PEG relevant to the goals of this
investigation. Obviously, the phosphate concentration used
here is signiﬁcantly higher than the one in the red blood cells.
Our failure to obtain crystals at low phosphate concentrations
suggests that in vivo crystallization of R-state HbC is
a complex phenomenon that depends on many factors. We
view the investigations reported here as a ﬁrst step in the
understanding of these processes.
EXPERIMENTAL PROCEDURES
Preparation of human HbC solutions
Theprocedures for isolation and puriﬁcation ofHbCand for preparation of the
solutions of CO-HbCwere identical to those described in Hirsch et al. (2001).
Growth of crystals on glass substrates for
AFM observations
Coverslips treated with trimethylchlorosilane were glued to iron disks and
used as glass substrates for AFM crystal growth studies. 20 ml aliquots of 20
mgmL1 CO-HbC in 1.9MKH2PO4/K2HPO4 at pH 7.35 were dispensed on
each disk. To avoid evaporation, the droplets were covered with glass covers,
hermetically sealed and kept for a few hours in a controlled temperature
chamber at ;22C. Typically, this led to the formation of 3–20 crystals of
sizes ranging from 20 to 200 mm ﬁrmly attached to the glass bottom. The
crystals always had the tetragonal bipyramid habit, consisting of eight {101}
faces, typical of the tetragonal crystals of R-state HbC (see, e.g., Hirsch et al.,
1988). Droplets with three to ﬁve crystals were selected and the crystals were
washed by 1.9M KH2PO4/K2HPO4, pH 7.35. The iron disks with the glass
covers holding the crystals were then magnetically mounted on the AFM
scanner. The ﬂuid AFM cell was ﬁlled with the crystallizing solution and
imaging commenced.
Atomic force microscopy observations
We used a multimode atomic force microscope Nanoscope IIIa (Digital
Instruments, Santa Barbara, CA). All images were collected in situ during
the growth of the crystals using the less intrusive tapping mode. This mode
allows visualization of adsorbed protein and impurity species—tip impact in
contact imaging mode often prevents such imaging. We used the standard
SiN tips. The tapping drive frequency was in the range of 25–31 kHz, within
the range used by other authors (Yip and Ward, 1996), adjusted to the
resonance value of the used tip. Other scanning parameters were adjusted
such that continuous imaging affected neither the surface structure nor the
process dynamics. For veriﬁcation, we varied the scan sizes and the time
elapsed between image collections, and saw that neither the spatial nor the
temporal characteristics of the processes changed. For details and tests about
the determination of the maximum resolution of 16 A˚, and the calibration of
the AFM imaging technique with other studied proteins, see Yau et al.
(2000a). For calibration of the AFM technique with HbC crystals, we note
that the experiments with HbC crystals in supersaturated solutions (see
below) revealed that the thickness of a layer on a (101) face is ;55 A˚, and
the periodicity along the [101]-axis is ;200 A˚, in agreement with the x-ray
crystal structure, according to which the respective values should be 53 and
202 A˚ (Dewan et al., 2002).
The characteristic shape of the crystals with the pyramid apex in the [001]
(or c) direction allowed an easy correlation between the crystallographic
directions and the AFM image orientation.
Temperature control and solubility
Temperature in the laboratory was stabilized to ;22C. No additional
temperature control of the solution in the AFM ﬂuid cell was employed.
Insertion of a thermocouple in the crystallizing solution revealed that its
temperature was 27 6 0.7C.
The solubility of CO-HbC in the solution with the used composition at
the temperature of the crystallization, ;27C, was determined by mon-
itoring trains of growth steps (see below) and gradually decreasing the
CO-HbC concentration in the solution. We found that at C ¼ 1.2 6 0.3 mg
mL1, the propagation of the steps stopped, and when the concentration
was lowered below this value, step movement was backward and the crystal
was dissolving. We assign the width of the solubility range to the high
sensitivity of the solubility to the concentration of the phosphate buffer:
slight variations in the buffer concentration between preparations result in
noticeable solubility variations. This value was chosen as the CO-HbC
solubility at the temperature of the experiments. It agrees with the value
extrapolated from the solubility in the 10–16C range by using the
crystallization enthalpy of 155 kJ mol1 (Vekilov et al., 2002).
RESULTS
The surface of crystals at equilibrium with
the solution
To image the surface of a (101) face of a tetragonal crystal of
CO-HbC at equilibrium with the solution, a solution with
CO-HbC concentration 1.5 mg mL1, slightly higher than
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the solubility at the temperature of the experiments, was
pumped into the AFM cell. In a few hours, we examined the
whole facet to verify that growth had stopped and
equilibrium had been reached. An image of the surface at
equilibrium is shown in Fig. 1 a. This and other similar
images reveal that the molecules in the top crystal layer are
arranged in four-molecule-wide strands. The strands are
oriented along a [010] direction. The strands are separated by
well-deﬁned groves, highlighted in Fig. 1 a. The four
molecules in the cross-section of a strand appear to be dif-
ferent and at ﬁrst sight this seems compatible with the crystal-
lographic symmetry group P41212 (Dewan et al., 2002).
Indeed, the 41 axis oriented along the [001] direction, i.e., at
an angle with the observed (101) face and perpendic-
ular to the [010] direction, rotates each of the four molecules
by 90 with respect to its neighbors in the quartet, exposing
different sides of the HbC molecule.
For a comparison with the bulk structure of the crystal,
Fig. 1, b and c, shows schematic images of the crystal surface
assuming that it reproduces the bulk crystal structure as
revealed in Dewan et al. (2002). These ﬁgures reveal that if
the crystal surface was fully determined by the bulk struc-
ture, neither the grooves nor the four member strands should
be present, i.e., the surface is reconstructed. The surface re-
construction is discussed in detail below.
The growth mechanisms: generation of new
crystal layers
Fig. 2 a and many other similar images reveal that the
crystals grow by a two step mechanism: 1), new layers are
generated by a surface nucleation process; and 2), these
layers incorporate building blocks from the solution and
spread to cover the whole facet. Note that the generation of
a subsequent layer occurs while the underlying layer is still
growing. This leads to many layers spreading and chasing
and meeting one another on the crystal surface. This
crystallization mechanism has been postulated by Volmer
in the 1930s (Volmer, 1939) and observed for numerous
small-molecule, protein and virus crystals (Giesen et al.,
1996; Malkin et al., 1996; McPherson et al., 2000; Yau et al.,
2000a; Yip and Ward, 1996).
In a few cases, we saw growth layers initiated by the
rotation of a spiral around a screw dislocation outcropping
on the monitored surface, Fig. 2 b. This mechanism is typical
for small-molecule materials (DeYoreo et al., 1994; Gratz
et al., 1993; Teng et al., 1998), and has been observed with
proteins (Durbin and Carlson, 1992; Durbin and Feher,
1996; Land et al., 1997; Malkin et al., 1996; Reviakine et al.,
2003). Note the hollow core around the dislocation axis. The
core lowers the strain due to the misﬁt of the lattice layers at
the screw dislocation. Its width is determined by the balance
of this strain with the surface free energy between the
solution and the crystal. A consistent thermodynamic theory
reveals that the core width also depends on the elastic
properties of the crystal and the supersaturation (Van den
Hoek et al., 1982; Vekilov et al., 1990). Hollow cores around
screw dislocation have been seen for many inorganic
(De Yoreo et al., 1997) and a protein crystal (Kuznetsov
et al., 1999). The signiﬁcance of the observation of hollow
cores with protein crystals is that it indicates that the elastic
properties of the protein crystals and their response to lattice
strain are not principally different from those of small-
molecule crystals (Chernov, 2003; Vekilov and Chernov,
2002).
The growth mechanisms: incorporation of
molecules into steps
Zooming in on the edge of the growing layer, Fig. 3, we ﬁnd
that the layer thickness is ;55 A˚—close to the prediction of
53 A˚ based on the x-ray structure (Dewan et al., 2002).
FIGURE 1 The structure of (101) surfaces of CO-HbC crystals at
equilibrium with solution. (a) Atomic force microscopy characterization
of a (101) surface of a CO-HbC crystal in equilibrium with the solution; for
details, see text. The (101) cross section of the unit cell is shown. White
arrows point at grooves between four-member strands along the b axis. (b
and c) Schematic representations of a 3 molecule 3 10 molecule section of
the (101) surface based on the x-ray crystal structure from Dewan et al.
(2002), PDP entry 1k1k. Black right angles only indicate orientation of
respective crystallographic directions and the lengths of the shoulders are not
related to the respective lattice parameters. Blue parallelograms represent
unit cells. Rendered using Swiss PDB Viewer. (b) View along the [101]
direction, analogous to viewing direction in a. (c) View along the [010]
direction, revealing the variations of the surface height. Arabic numerals
mark the four molecules in a unit cell.
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Furthermore, we see that the molecular rows along the a (or
b) axes are in perfect alignment with the underlying layers, as
one would expect for the tetragonal lattice of the CO-HbC
crystals. The edge of the unﬁnished layers is rough, and the
characteristic lengthscale of the roughness equals one
molecular dimension. This is only possible if molecules join
the crystal one by one. We conclude that the building blocks
of CO-HbC crystals are single protein molecules.
The sequence in Fig. 4 reveals that as the molecules attach
to the edges of unﬁnished top crystal layers, these layers
advance and the crystal grows. No correlation exists between
the direction of motion of the steps and the crystallographic
directions, in agreement with the lower magniﬁcation images
in Fig. 2, which shows isotropic spreading of the islands and
a round dislocation core. Fig. 5 compares the step velocities
in the [101], [010] , and [111] crystallographic directions
computed from the respective displacements of steps
between pairs of images in Fig. 4. We see that the velocities
are not steady and randomly change in time because of the
intrinsic stochasticity of the molecular incorporation pro-
cesses, i.e., the number of molecules joining the step for
a certain time is a random variable over the times of imaging
in Fig. 4. Still, if we average the data for each direction in
Fig. 5, we get roughly equal averages, in agreement with the
isotropy of step propagation discussed above.
The average velocity from the data in Fig. 6 is v ¼ 1.1 nm
s1. We can use this value for a rough evaluation of the step
kinetic coefﬁcient b, a parameter characterizing the time-
averaged kinetics of incorporation of the HbC molecules into
crystals. We use the deﬁnition of b (Chernov, 1984)
v ¼ bVðC CeÞ;
where C and Ce are, respectively, the HbC concentration and
its solubility in molecules per unit volume, so that Ce ¼ 1.1
FIGURE 2 Mechanisms of layer generation. (a) Layer generation by two-
dimensional nucleation, a newly generated layer is indicated by a black
arrow, CCO-HbC ¼ 3 mg mL1. This is a more detailed ﬁgure from Vekilov
et al. (2003). (b) A screw dislocation, with hollow core (white arrow points
at the center of the hollow core) around it and spiral step that it generates;
note that the spiral is left-winged on the crystal surface and right-winged
inside the hollow core. CCO-HbC ¼ 1 mg ml1 approximate solubility.
FIGURE 3 Spreading of growth layers with each higher layer in perfect
crystallographic alignment with the respective lower layer. White dashed
lines highlight continuity between two layers of linear features in a [010]
direction. CCO-HbC ¼ 2 mg mL1. From Fig. 3 in Vekilov et al. (2002).
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3 1015 cm3, and V ¼ ¼(54 3 195 3 195) A˚3 ¼ 5.1 3
1019 cm3 (Dewan et al., 2002) is the volume that a molecule
occupies in the crystal. We get b  2 3 105 cm s1, at the
lower end of the range of b for other proteins, 102 – 105
cm s1 (Reviakine et al., 2003).
Fig. 6 shows that as the steps move along the face, they do
not stay equidistant. Areas of high and low step density form.
It has been shown that variable step density, also called step
bunching, leads to crystal nonuniformity and lower quality
and utility of protein crystals (Vekilov and Rosenberger,
1998b).
Impurities and crystal growth
Dynamic light scattering investigations of crystallizing CO-
HbC solutions revealed that aggregates of HbC form in
solutions of concentrations higher than a few mg mL1; a
typical distribution of the protein species is shown in Fig. 7 a
(for details about the technique, see Vekilov et al., 2002). In
contrast to the distribution in low-concentration HbC
solutions, which show a monodisperse sample with
a characteristic molecular size of 5.5 nm (Vekilov et al.,
2002), the distribution in Fig. 7 a shows the presence of at
least two populations. The smaller-size population has an
apparent mean diameter of 9 nm and these are likely the
native HbC molecules. The increase from the typical size of
the HbC molecules of 5.5 nm is attributable to the
intermolecular attraction in the high-phosphate buffer
solution that leads to lower diffusion coefﬁcient (Schmitz,
1990). The lower diffusivity is interpreted by the data-
processing algorithms as a size increase (Provencher, 1979,
1982a,b). The larger size population has a mean size of 30
nm and these are likely aggregates of HbC molecules. AFM
monitoring of the growth interface revealed that the
aggregates are strongly adsorbed at the growth interface,
FIGURE 4 A series of molecular resolution images of step propagation.
Time between pairs of images is always 35 s. Direction of slow scanning
indicated on right side of each panel. Note that the bottom part of the lower
step moving in [101] direction is signiﬁcantly faster than step motion in the
other directions. CCO-HbC ¼ 2.2 mg mL1.
FIGURE 5 Variations of the velocities of the steps in Fig. 4 in three
crystallographic directions. Data at 35 s extracted by comparing step
locations in the ﬁrst and third images in Fig. 4; data at 70 s—from step
locations in the third and ﬁfth images. Within these pairs, the images were
taken with the same scanning direction. The upper data points labeled [101]
are for the fast lower step in Fig. 4.
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where they may serve as centers for the nucleation of new
crystal layers. Fig. 7 b shows that the adsorbed aggregates
often pin down the growth layers and slow down their
propagation. Cross-section proﬁles of the images of the
aggregates in Fig. 7 b and in other images with higher
magniﬁcation reveal that their vertical dimensions are in the
range 10–40 nm (the lateral dimensions may be misleading
because of tip-sample convolution effects). This roughly
agrees with the 30-nm aggregates detected by the light
scattering determination in Fig. 7 a.
DISCUSSION
The growth mechanism
The surfaces of crystals, illustrated by Fig. 1 a, possess an
unexpected feature: four-member strands along the a (or b)
crystallographic axis, separated by well-deﬁned grooves.
This arrangement violates the crystallographic symmetry.
For better understanding of the suspected reconstruction, in
Fig. 1, b and c, we display the molecular arrangement of the
FIGURE 6 Variable density of steps during crystal growth. (a) Uniformly
low step density at CHbC¼ 4 mg mL1 in 1.9 M phosphate buffer at pH 7.35
at 25C, i.e., at C/Ceq ¼ 3.3. (b) Regions of high and low step density at
CHbC ¼ 6 mg mL1, i.e., at C/Ceq ¼ 5.0.
FIGURE 7 HbC aggregates and their effects on growth. (a) Dynamic light
scattering characterization of a solution of HbC with CCO-HbC ¼ 8.5 mg
mL1. (b) Typical image of aggregates of ;30–40 nm adsorbed on the
surface at HbC concentration higher than 7–8 mg mL1. Arrows indicate
instances of growth steps pinned by the aggregates.
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(101) plane in the crystal bulk. The molecular arrangement
of the (101) surface layer compatible with the structure of the
crystal bulk in Fig. 1, b and c, is not unique. If one allows for
a surface that contains incomplete crystallographic cells,
other arrangements may obtain. For instance, one can add
a molecule symmetrically equivalent to the molecule labeled
1 in Fig. 1 c in the crevice formed by molecules in positions
equivalent to 4, 1, and 2. A second new conﬁguration is
produced by adding a molecule in position 2 to the newly
formed crevice, and so on. In all cases, the structures reveal
four molecules so tightly packed that one of them is partially
covered by its neighbor in the [101] direction. None of the
produced structures possess the essential feature of Fig. 1
a—four-member strands separated by grooves. Thus, we
conclude that the surface layer of the crystal, as seen in Fig. 1
a and other similar images is ‘‘reconstructed’’; numerous
instances of reconstruction of the surface layers of inorganic
crystals have been documented (Swartzentruber, 1998;
Williams and Bartelt, 1991).
The four-molecule-wide strands on the surfaces of the CO-
HbC crystals are akin to the two-member strands observed
by electron microscopy on the surface of HbS crystals grown
from solutions containing PEG (Bluemke et al., 1988; Lessin
et al., 1969; Makinen and Sigountos, 1984; Potel et al.,
1984). In these studies, the presence of such strands was the
main piece of evidence supporting the conclusion of a growth
mechanism of HbS crystal involving alignment of the
preformed ﬁbers in the solution. Since ﬁbers, ribbons, and
other linear objects have been observed in crystallizing
solutions of CO-HbC (Hirsch et al., 2001), one may
speculate that the observations of the strands support the
ﬁber-alignment mechanism of formation of HbC crystals.
However, the results in Figs. 3 and 4 above unambiguously
show that the growth of crystals occurs by the attachment of
single molecules. In another article (Vekilov et al., 2002),
we presented compelling evidence that the nucleation of the
CO-HbC crystal is also a process of self-assembly of single
molecules and the microribbons and other noncrystalline
phases present in the solution only play auxiliary roles in the
crystallization process. The overall conclusion emerging
from these investigations is that the crystallization mecha-
nisms of HbC, in concentrated phosphate buffer, are by no
means different from those found for other proteins (see, e.g.,
McPherson, 1999; McPherson et al., 2000; Yau et al.,
2000a).
Impurities and crystallization
The observations of the impurity effects on the growth of
HbC crystals provide some additional insight into a general
issue of protein crystallization—that of the nature and role of
impurity species. It is commonly thought that crystallization
is a method for protein puriﬁcation. However, there have
been numerous crystal growth studies wherein crystal
imperfections arise from the incorporation of ‘‘impurities,’’
e.g., (Vekilov, 2003). It was found that ‘‘impurities,’’ i.e.,
microheterogeneous molecules of the crystallizing protein,
(e.g., aggregates and clusters of this protein, other protein
molecules remaining in the solution after isolation and
puriﬁcation, as well as small molecular compounds) affect
growth and are often abundantly incorporated into the
crystals.
Several detailed studies were carried out with the proteins
lysozyme and ferritin (or apoferritin). For both proteins the
impurity species that remains in the solution even after
laborious puriﬁcation is a dimer of the native molecules,
likely because of its chemical similarity to the native protein
(Thomas et al., 1996, 1997, 1998).
With lysozyme, the dimer has an isometric shape and
contains two covalently boundmonomer chains. It was shown
to severely affect the shape of the interface, reduce the growth
rate by factors of up to 5, and completely inhibit growth at low
supersaturations (Thomas et al., 1996, 1998; Vekilov, 1993;
Vekilov et al., 1995; Vekilov and Rosenberger, 1996). It was
found that the dimers are preferentially incorporated into the
crystals and exhibit severely nonuniform distribution with
a core of very high impurity incorporation in the central
regions of a crystal (Stojanoff et al., 1997; Vekilov et al.,
1996b). It was also found that impurities adsorbed on the
growth interface cause severe growth unsteadiness and step
bunching (Vekilov and Alexander, 2000; Vekilov et al.,
1996a; Vekilov and Rosenberger, 1998a). The nonuniform
impurity incorporation and the step bunching have been
shown to cause high levels of lattice strain, structural
nonuniformities and mosaicity (Caylor et al., 1999; Chernov,
1998, 1999; Dobrianov et al., 1998; Yau et al., 2001).
With ferritin, the ‘‘dimers’’ consist of two slightly
misfolded native spheres held together by hydrophobic
bonds (Petsev et al., 2000). As with lysozyme, they are
preferentially incorporated into the crystals (Thomas et al.,
2000). Each incorporated dimer causes stacks of trivacancies
and single vacancies up to ﬁve molecular layers high (Yau
et al., 2001, 2000b). The vacancies stress the crystal lattice,
and the accumulated strain is resolved by the breaking of
crystals larger than 100–200 mm into mosaic blocks of ;50
mm in size (Yau et al., 2001).
The relatively large aggregates of evidence in Fig. 7 are
similar to those for crystallization of ferritin and lysozyme in
that they consist of the crystallizing protein. In further
similarity, the impurities are incorporated into the crystals
and severely affect growth. However, there are some
signiﬁcant differences. The HbC aggregates are large and
contain multiple native or denatured molecules. While the
lysozyme and ferritin dimers exist before crystallization and
could, potentially, be removed with a high-sensitivity
technique, the HbC aggregates form only after a high-
concentration crystallization solution is prepared. Thus, they
are a constant companion of crystallization and can only be
avoided if a different set of crystallization conditions is
employed. While it has been known (Ferre-D-Amare and
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Burley, 1994) that protein aggregation should be avoided for
successful protein crystallization, it was thought that this is
because aggregation provides an alternative pathway to
lower the supersaturation of a concentrated protein solution.
The above observations with HbC show that even when the
aggregate concentration is too low and aggregation cannot be
a real competition to crystal formation, aggregates can still
interfere with the growth of perfect crystals.
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